The current study indicated that Plin4, Sgk1, Klf2 and Dcaf12l1 were differentially expressed in depression models treated with ketamine, phencyclidine and memantine, which suggested that these genes may be the targets of the NMDA receptor antagonist treatment. The gene discussed is DCAF12L1; the disease is depressive disorder.